4-1003418-C-T
Variant summary
Our verdict is Pathogenic. Variant got 16 ACMG points: 16P and 0B. PM2PM5PP3_StrongPP5_Very_Strong
The NM_000203.5(IDUA):c.1598C>T(p.Pro533Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000145 in 1,376,970 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P533R) has been classified as Pathogenic.
Frequency
Consequence
NM_000203.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 16 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome AF: 0.00000145 AC: 2AN: 1376970Hom.: 0 Cov.: 33 AF XY: 0.00000147 AC XY: 1AN XY: 679424
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Mucopolysaccharidosis type 1 Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Aug 22, 2023 | For these reasons, this variant has been classified as Pathogenic. This variant disrupts the p.Pro533 amino acid residue in IDUA. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 1301941, 10911525, 16435195, 21521498, 23786846, 24368159). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt IDUA protein function. This missense change has been observed in individuals with mucopolysaccharidosis (PMID: 9787109, 27511503). This variant is not present in population databases (gnomAD no frequency). This sequence change replaces proline, which is neutral and non-polar, with leucine, which is neutral and non-polar, at codon 533 of the IDUA protein (p.Pro533Leu). - |
Likely pathogenic, criteria provided, single submitter | curation | Broad Center for Mendelian Genomics, Broad Institute of MIT and Harvard | Jan 13, 2020 | The p.Pro533Leu variant in IDUA has been reported in 4 individuals with mucopolysaccharidosis (MPS) (PMID: 9787109, 27511503; doi: 10.7124/bc.00093B) and was absent from large population studies and no high quality genotypes at this site were noted to include this variant. This variant has also been reported in ClinVar (VariationID: 429205) as likely pathogenic by EGL Genetic Diagnostics. Computational prediction tools and conservation analyses suggest that this variant may impact the protein, though this information is not predictive enough to determine pathogenicity. One additional pathogenic variant, resulting in a different amino acid change at the same position, p.Pro533Arg, has been reported in association with disease in the literature and ClinVar, supporting that a change at this position may not be tolerated (VariationID: 11910; PMID: 24036510, 28752568, 27196898, 19748810). The p.Pro533Leu variant is located in a region of IDUA that is essential to protein folding and stability, suggesting that this variant is in a functional domain and supports pathogenicity (PMID: 24480078, 9787109, 27511503). The presence of this variant in one affected homozygote and in combination with a reported pathogenic variant in 2 individuals with MPS increases the likelihood that the p.Pro533Leu variant is pathogenic (VariationID: 11909; PMID: 9787109, 27511503; doi: 10.7124/bc.00093B). In summary, although additional studies are required to fully establish its clinical significance, this variant is likely pathogenic. ACMG/AMP Criteria applied: PM5, PM3, PM1, PM2_supporting, PP3 (Richards 2015). - |
not provided Pathogenic:1Other:1
not provided, no classification provided | clinical testing | GeneDx | - | The P533R variant in the IDUA gene has been reported previously in the homozygous state or in the heterozygous state with a presumed second IDUA variant in individuals with MPS I (Alif et al., 1999; Laradi et al., 2005; Fahiminiya et al., 2014). The P533R variant is not observed in large population cohorts (Lek et al., 2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server). The P533R variant is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. This substitution occurs at a position that is conserved across species. Functional studies of P533R indicate that this variant leads to a 50% reduction in the enzymatic rate of IDUA and confers lower thermodynamic stability compared to wild type protein (Bie et al., 2013). A missense variant in the same residue, P533L, has been previously identified in the heterozygous state with a second IDUA variant in two individuals with MPS I (Voskoboeva et al., 1998). Therefore, we interpret P533R as a pathogenic variant. - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | May 08, 2017 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at